Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Ways To Make Money Online Without A Job
Discover various ways to make money online without needing a traditional job. Start your online earning journey now.
22,635 articles
Federal Funding Mixed Housing Draws Mixed Reactions
House appropriators moved a fiscal 2027 THUD bill that preserves key housing programs but hints at reductions elsewhe...
U.S. Economy Slows 2026: 3 Dividend ETFs That Hold Up
As signs point to a softer economy in 2026, dividend-focused ETFs can provide ballast. This guide identifies three re...
2026 Earnings Transcript: Key Takeaways for Investors
A clear guide to understanding the 2026 earnings transcript and turning quarterly numbers into actionable investing i...
Crypto Price Analysis Jun-05: ETH, XRP, ADA, BNB, HYPE
On Jun-05, Ethereum, XRP, ADA, BNB, and HYPE trade near critical levels as traders weigh support zones against renewe...
MercadoLibre Stock Headed $2,800? Analysts Weigh In
Could mercadolibre stock headed $2,800? be more than a headline. This deep dive examines growth drivers, risks, and h...
Buy, Hold, Sell: Arm Holdings Under Hawkish Fed Pressure
Arm Holdings faces macro headwinds as the Fed signals restraint. Investors are weighing a buy, hold, sell: holdings f...
Blue Origin's Rocket Blew: What It Means for SpaceX
When headlines scream about a space setback, investors shift their bets. This article breaks down how Blue Origin’s r...
Choice Hotels' Interim Sold: What It Means for Investors
When a hotel group’s interim CEO sells a sizable stake, investors want to know if it’s a sign of trouble or routine f...
Billionaire Philippe Laffont Says a $10T AI Era Is Near
A leading investor foresees a future where agentic AI unlocks massive productivity gains, enabling a company to reach...
What Know About This Insider Sale After Check Point Drop
An oversized insider trade at Check Point Software followed a sharp stock decline. Learn how to interpret this move, ...
This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status